ArticleOncotarget2016

Augmentation of response to nab-paclitaxel by inhibition of insulin-like growth factor (IGF) signaling in preclinical pancreatic cancer models.

Niranjan Awasthi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.